Tissue Procurement for Biomedical Research

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2013 by National Institutes of Health Clinical Center (CC).
Recruitment status was  Recruiting
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute on Aging (NIA) )
ClinicalTrials.gov Identifier:
First received: September 12, 2005
Last updated: June 5, 2014
Last verified: July 2013
The purpose of this study is to obtain human tissue samples for scientific study.

Cardiovascular Diseases
Endocrine Diseases
Neurological Disorders
Mental Disorders

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Tissue Procurement

Further study details as provided by National Institutes of Health Clinical Center (CC):

Primary Outcome Measures:
  • Exploratory studies for methods development and disease correlations [ Time Frame: Ongoing ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA
blood, urine, saliva, sweat, pleural, pericardial, ascitic, synovial, cerebrospinal fluids

Estimated Enrollment: 5000
Study Start Date: February 2003
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Detailed Description:
Researchers frequently need tissue samples (blood, urine, saliva, sweat, or other body fluid/tissue) to help them understand more about a particular disease or process. This protocol is designed to create the opportunity to obtain such samples that would otherwise be discarded during the course of usual clinical care, or alternatively to obtain such samples during patient screening for other studies.

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Inclusion Criteria:

  • 18 years of age or older
  • Identified by the investigator to have a condition of interest (cardiovascular disease, cancer, endocrine disease, neurological disease, arthritis, psychiatric disease) for exploratory studies related to the patient's illness or other feature that offers the possibility of generation of hypotheses for future studies

Exclusion Criteria:

  • Unwilling to be subjected to diagnostic and/or therapeutic procedures that are not necessary for clinical management
  • Excessive blood loss in this study plus other research participation and/or clinical evaluation that will result in blood loss of greater than 1 unit (400ml or 1 pint) over an 8 week period
  • Inability to give informed consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00182858

Contact: NIA Recruiter 410-350-3941 NIAStudiesRecruitment@mail.nih.gov

United States, Maryland
National Institute on Aging (NIA), MedStar Harbor Hospital Recruiting
Baltimore, Maryland, United States, 21225
Contact: NIA Recruiter    410-350-3941    NIAStudiesRecruitment@mail.nih.gov   
Principal Investigator: Nazli McDonnell, MD, Ph.D.         
Sponsors and Collaborators
National Institute on Aging (NIA)
Principal Investigator: Nazli McDonnell McDonnell, MD National Institute on Aging, Laboratory of Clinical Investigation
  More Information

Additional Information:
No publications provided

Responsible Party: National Institutes of Health Clinical Center (CC) ( National Institute on Aging (NIA) )
ClinicalTrials.gov Identifier: NCT00182858     History of Changes
Obsolete Identifiers: NCT01927796
Other Study ID Numbers: AG0039,03-AG-N322  999903322 
Study First Received: September 12, 2005
Last Updated: June 5, 2014
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):

Additional relevant MeSH terms:
Cardiovascular Diseases
Endocrine System Diseases
Mental Disorders
Nervous System Diseases
Psychotic Disorders
Pathologic Processes
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on February 04, 2016